Kyntra Bio (MEX:KYNB) Short Interest


MEX:KYNB Kyntra Bio Inc MEX:KYNB
35 GF Score
Price MXN118.50
GF Value MXN94.05
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is Kyntra Bio Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

MEX:KYNB vs SER, SNSE, PVCT: Short Interest Comparison

For the Biotechnology subindustry, Kyntra Bio's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kyntra Bio Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kyntra Bio's Short Interest distribution charts can be found below:

* The bar in red indicates where Kyntra Bio's Short Interest falls into.


MEX:KYNB
35GF Score
Kyntra Bio Inc MEX:KYNB
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Kyntra Bio (MEX:KYNB) Overvalued in 2026?

Based on GuruFocus' analysis, Kyntra Bio stock appears to be overvalued. The current stock price of MXN118.50 is trading 26% above its estimated GF Value™ of MXN94.05. GuruFocus considers Kyntra Bio to be Modestly Overvalued.

Key valuation signals for MEX:KYNB:

  • Short Interest:
  • GF Value™: MXN94.05 vs. price of MXN118.50 (26% above fair value)
  • GF Score™: 35/100 with 8 warning signs

No single metric tells the full story. See the MEX:KYNB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Kyntra Bio Business Description

Other Exchanges KYNB:USA0IL8:UK1FG0:Germany
Address 350 Bay Street, Suite 100, No. 6009, San Francisco, CA, USA, 94133
Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.
35GF Score

Get the complete analysis for MEX:KYNB

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN118.50
Price
MXN94.05
GF Value